Showing results (11-20 of 361) with videos related to
Sort By:
Pageof 37
Blood Purification|June 6, 2013
Therapy of anemia: is it only a number to reach or are there other variables to control?Lucia Del Vecchio, Francesco LocatelliExpert Opinion on Biological Therapy|March 4, 2014
New treatment approaches in chronic kidney disease-associated anaemiaLucia Del Vecchio, Francesco LocatelliContributions to Nephrology|June 1, 2011
New erythropoiesis-stimulating agents and new iron formulationsFrancesco Locatelli, Lucia Del VecchioExpert Review of Cardiovascular Therapy|March 26, 2015
Cardiovascular mortality in chronic kidney disease patients: potential mechanisms and possibilities of inhibition by resin-based phosphate bindersFrancesco Locatelli, Lucia Del VecchioJournal of Nephrology|July 19, 2017
Iron-based phosphate binders: a paradigm shift in the treatment of hyperphosphatemic anemic CKD patients?Francesco Locatelli, Lucia Del VecchioExpert Review of Hematology|July 16, 2014
Anemia in chronic kidney disease patients: treatment recommendations and emerging therapiesLucia Del Vecchio, Francesco LocatelliContributions to Nephrology|May 3, 2008
New erythropoiesis-stimulating agents: how innovative are they?Lucia Del Vecchio, Francesco LocatelliHemodialysis International. International Symposium on Home Hemodialysis|April 25, 2017
Clinical practice guidelines on iron therapy: A critical evaluationLucia Del Vecchio, Francesco LocatelliKidney International|May 20, 2023
Quality of life: a crucial aspect for the patients, a neglected goal in the treatment of anemia in patients with CKDFrancesco Locatelli, Lucia Del VecchioExpert Opinion on Investigational Drugs|July 6, 2018
Investigational hypoxia-inducible factor prolyl hydroxylase inhibitors (HIF-PHI) for the treatment of anemia associated with chronic kidney diseaseLucia Del Vecchio, Francesco LocatelliPageof 37